Literature DB >> 24689214

Antiproliferative effects of 12-oxoheteronemin vs heteronemin.

Siriporn Kittiwisut, Cristina C Rohena, Supreeya Yuenyongsawad, Susan L Mooberry, Anuchit Plubrukarn.   

Abstract

The antiproliferative activities of 12-oxoheteronemin and heteronemin were evaluated in six cancer cell lines and IC50 values ranging from 0.66 to 1.35 microM were obtained. In four of the cell lines, 12-oxoheteronemin and heteronemin were equipotent; however, in two estrogenic receptor-positive cell lines, heteronemin showed a stronger potency. Both compounds had no overt effects on cell cycle distribution in HeLa cells, but did rapidly initiate apoptosis as evidenced by increased sub-G1 populations of cells and caspase-dependent PARP cleavage.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24689214

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  2 in total

Review 1.  The power of heteronemin in cancers.

Authors:  Kuan Wang; Yi-Fong Chen; Yu-Chen S H Yang; Haw-Ming Huang; Sheng-Yang Lee; Ya-Jung Shih; Zi-Lin Li; Jacqueline Whang-Peng; Hung-Yun Lin; Paul J Davis
Journal:  J Biomed Sci       Date:  2022-06-15       Impact factor: 12.771

2.  Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells.

Authors:  Sukanya Unson; Tung-Cheng Chang; Yung-Ning Yang; Shwu-Huey Wang; Chi-Hung Huang; Dana R Crawford; Haw-Ming Huang; Zi-Lin Li; Hung-Yun Lin; Jacqueline Whang-Peng; Kuan Wang; Paul J Davis; Wen-Shan Li
Journal:  Mar Drugs       Date:  2022-07-27       Impact factor: 6.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.